Int J Biol Sci 2017; 13(2):219-231. doi:10.7150/ijbs.16725 This issue

Research Paper

Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury

Yanjun Long1,2, Xin Zhen1, Fengxin Zhu1, Zheng Hu1, Wenjing Lei1, Shuang Li1, Yan Zha 2, Jing Nie1✉

1. State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, P.R. China;
2. Division of Nephrology, Guizhou Provincial People's Hospital, Guizhou Provincial Institute of Nephritic & Urinary Disease, Guiyang, P.R. China.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See for full terms and conditions.
Long Y, Zhen X, Zhu F, Hu Z, Lei W, Li S, Zha Y, Nie J. Hyperhomocysteinemia Exacerbates Cisplatin-induced Acute Kidney Injury. Int J Biol Sci 2017; 13(2):219-231. doi:10.7150/ijbs.16725. Available from

File import instruction


Graphic abstract

Hyperhomocysteinemia (HHcy) has been linked to several clinical manifestations including chronic kidney disease. However, it is not known whether HHcy has a role in the development of acute kidney injury (AKI). In the present study, we reported that HHcy mice developed more severe renal injury after cisplatin injection and ischemia-reperfusion injury shown as more severe renal tubular damage and higher serum creatinine. In response to cisplatin, HHcy mice showed more prevalent tubular cell apoptosis and decreased tubular cell proliferation. Mechanistically, a heightened ER stress and a reduced Akt activity were observed in kidney tissues of HHcy mice after cisplatin injection. Stimulating cultured NRK-52E cells with Hcy significantly increased the fraction of cells in G2/M phase and cell apoptosis together with decreased Akt kinase activity. Akt agonist IGF-1 rescued HHcy-induced cell cycle arrest and cell apoptosis. In conclusion, the present study provides evidence that HHcy increases the sensitivity and severity of AKI.

Keywords: Hyperhomocysteinemia, AKI, apoptosis, cell proliferation, ER stress.